News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

CSIRO Denies Deceiving Novartis AG (NVS) Over Anti-Counterfeiting Technology


6/4/2013 7:17:13 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Fairfax Media has reported the Government's scientific organisation bought cheap chemicals in China. It says in 2011, the chemicals were sold to Novartis as an anti-counterfeiting technology to protect medicines from being cloned by criminals making fake pharmaceuticals. The chemicals were reportedly marketed to Novartis by DataTrace DNA, which was a joint venture between CSIRO and another company, Datadot Technology. CSIRO's chief Mike Whelan has told a Senate Estimates committee the organisation is still investigating the matter but has come to a number of preliminary conclusions. "There is no evidence that CSIRO deceived or wilfully misled DataTrace or Novartis as to the supply of material," he said.

Help employers find you! Check out all the jobs and post your resume.

Read at ABC (Australia)
Read at News Release

comments powered by Disqus
CSIRO
Novartis AG
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES